Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Vemax Pharma is a Greek pharmaceutical company dedicated to the development, promotion, and distribution of high-quality pharmaceutical products, medical devices, and food supplements. Headquartered in Athens, the company maintains a strong presence in therapeutic areas such as gastroenterology, urology, gynecology, and orthopedics. Their portfolio includes specialized formulations for irritable bowel syndrome, urinary tract health, and joint support, often utilizing evidence-based ingredients. Vemax Pharma operates with a focus on the Greek healthcare market, leveraging a professional network of medical representatives to reach healthcare providers and pharmacists. The company emphasizes innovation and quality standards in its product offerings to improve patient quality of life. They also act as a local partner for international pharmaceutical firms looking to enter the Greek market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Vemax Pharma.